Sex- specific differences in suspected myocarditis presentations and outcomes

Jonathan Schütze,Noah Greisser,Philippe Joss,Catherine Gebhard,Benedikt Bernhard,Simon Greulich,Anselm W Stark,Yasaman Safarkhanlo,Maryam Pavlicek,Moritz Hundertmark,Isaac Shiri,Raymond Kwong,Christoph Gräni
DOI: https://doi.org/10.1016/j.ijcard.2024.132593
2025-01-01
Abstract:Background: Signs and symptoms of myocarditis may vary among men and women. Objectives: This study aimed to analyze sex-specific differences in the presentation and outcomes of patients with suspected myocarditis. Methods: Patients meeting clinical ESC criteria for suspected myocarditis were included from two tertiary centers between 2002 and 2021. Baseline characteristics, cardiac magnetic resonance (CMR), and outcomes (i.e. major adverse cardiovascular events (MACE), including all-cause death, ventricular tachycardia, hospitalization for heart failure, and recurrent myocarditis) in women and men were compared. Results: 776 consecutive patients (mean age 48 ± 16 years, 286 [36.9 %] women) were followed for a median of 3.7 years. Compared to men, women presented more often with severe dyspnea (NYHA III-IV: 25.9 % versus 19.2 % of men; p = 0.029), while chest pain was more frequent in men (39.8 % versus 32.2 % in women; p = 0.037). There was no difference in left ventricular ejection fraction at the time of presentation (women: 48.5 ± 15.4 % versus men: 48.6 ± 15.1 %;p = 0.954). Further, no sex-specific difference in the occurrence of MACE was noted; however, women were more often hospitalized for heart failure than men (women: 9.8 % versus men: 5.3 %, p = 0.018). Accordingly, female sex was independently associated with heart failure hospitalization in an adjusted model (HR: 2.31, 95 % CI:1.25-4.26; p = 0.007). The prognostic value of CMR markers was similar in both sex. Conclusion: Significant sex-specific differences in presentations and imaging findings are found in patients with suspected myocarditis. Female sex is associated with a twofold increase in the risk of heart failure hospitalization, which should be considered in risk stratification.
What problem does this paper attempt to address?